
Tim Mitchell
Consultant Gastroenterologist and Hepatologist at Royal Perth Hospital, Perth, Western Australia.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
Aug 30, 2026
How to diagnose PFIC and treat with IBAT inhibitors (Live from AGW 2026)
2:48
2:55
2:59
3:07

Tim MitchellGUEST
The usual way to approach it is to really sort of look at the GTT and they're probably two main subgroups.

Tim MitchellGUEST
There's people with maybe a primary cholestasis which may be a hepatocyte cholestasis.

Tim MitchellGUEST
They can't get rid of the bile from their hepatocytes and then there's another group which has more of a cholangitis.

Tim MitchellGUEST
or a cholangiopathy type presentation where the bile is damaging their bile ducts and their biliary tree.
6:12
And how do you explain genetic testing and how do you interpret a variant of uncertain significance?
